Immatics Announces Second Quarter 2024 Financial Results and Business Update Aug 13, 2024 07:00AM
Immatics (IMTX) Reports Interim Clinical Data from Ongoing Phase 1b trial of ACTengine IMA203 TCR-T May 2, 2023 07:01AM
Immatics Reports Interim Clinical Data from Ongoing Phase 1b Cohort A Monotherapy with ACTengine® IMA203 TCR-T Targeting PRAME May 2, 2023 07:00AM
Immatics (IMTX) Reports FY22 Results, Issues Corporate Update Mar 21, 2023 07:33AM
Immatics Announces Full Year 2022 Financial Results and Corporate Update Mar 21, 2023 07:31AM


Nov 17, 2022 07:00AM Immatics Announces Third Quarter 2022 Financial Results and Business Update
Aug 9, 2022 07:00AM Immatics Announces Second Quarter 2022 Financial Results and Business Update
Jun 2, 2022 07:07AM Immatics (IMTX) Reports Q1 Revenue of $114.2M, Net Income of $95.1M
Jun 2, 2022 07:05AM Immatics Announces First Quarter 2022 Financial Results and Business Update
Mar 23, 2022 07:00AM Immatics Announces Full Year 2021 Financial Results and Corporate Update
Nov 16, 2021 07:00AM Immatics Announces Third Quarter 2021 Financial Results and Provides Business Update
Aug 10, 2021 07:00AM Immatics Announces Second Quarter 2021 Financial Results and Provides Business Update
May 18, 2021 07:00AM Immatics Announces First Quarter 2021 Financial Results and Business Update
Mar 30, 2021 07:00AM Immatics Announces Full Year 2020 Financial Results and Corporate Update
Dec 2, 2020 07:00AM Immatics Announces Third Quarter 2020 Financial Results and Business Update
Sep 3, 2020 07:00AM Immatics Announces Second Quarter 2020 Financial Results and Business Update